With the growing pipeline of biologics, increase in vaccine production, and trends toward smaller batch sizes targeting smaller patient populations, there is increasing demand for advanced manufacturing technologies. These parenteral drugs require advanced facilities and equipment for fill/finish operations to ensure product quality and safety. As pharmaceutical, biotech companies, and contract development and manufacturing organizations (CDMOs) look to build or expand manufacturing capabilities, there are several factors that need to be evaluated: maximization of floorspace, reduced risk of cross-contamination, manufacturing flexibility, varying throughput, tech transfer, and various primary packaging formats. Today’s fill/finish equipment technologies present various options to meet many of today’s manufacturing requirements.

Key Considerations for Selecting Fill/Finish Manufacturing Technologies

What can you do to minimize risk as you transition to a combination product?

Download our free e-book for insight on ways to:

Read time :  clock 4 minutes

Reducing Risk IconReduce Development and Supply Risk

Accelerate IconAccelerate Your Path to Market

Eye IconNavigate a regulatory landscape for combination products

Vial IconSelect the right components & system for your drug application